Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
45 NOK | 0.00% |
|
-1.75% | +8.43% |
04-30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.43% | 66.06M | |
-2.58% | 8.27B | |
+9.13% | 5.81B | |
+29.76% | 5.58B | |
-15.77% | 3.85B | |
+12.42% | 2.71B | |
-61.85% | 2.56B | |
-7.24% | 2.42B | |
+23.09% | 2.13B | |
-9.25% | 1.77B |
- Stock Market
- Equities
- GENT Stock
- News Gentian Diagnostics
- Gentian Diagnostics as Appoints Njaal Kind as Group Chief Financial Officer